Company Profiles

driven by the PitchBook Platform

NanoBio

Description

Provider of vaccines designed to prevent respiratory diseases and offer mucosal immunity. The company's vaccines with adjuvant technology elicit both systemic and mucosal immune responses, enable its clients to protect themselves from world's most severe respiratory and sexually transmitted diseases that enter inside the body through mucosal surfaces.

2000

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$775k

Latest Deal Amount

$71.5M

Total Amount Raised

Description

Provider of vaccines designed to prevent respiratory diseases and offer mucosal immunity. The company's vaccines with adjuvant technology elicit both systemic and mucosal immune responses, enable its clients to protect themselves from world's most severe respiratory and sexually transmitted diseases that enter inside the body through mucosal surfaces.

Website:

www.nanobio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Therapeutic Devices
Biotechnology

Primary Office

2311 Green Road Suite A Ann Arbor, MI 48105United States +1 (734) 302-4000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NanoBio's full profile, request a free trial.

NanoBio Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NanoBio Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

NanoBio Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Centre Lane PartnersPE/BuyoutMinority000 0000000 0000
Lawrence BlackAngel (individual)Minority000 0000000 0000
Line Moon VenturesOtherMinority000 0000000 0000
Michigan Investment in New Technology StartupsVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernmentMinority000 0000000 0000
Centre Lane Partners PE/Buyout
Lawrence Black Angel (individual)
Line Moon Ventures Other
Michigan Investment in New Technology Startups Venture Capital
National Institutes of Health Government

NanoBio Executive Team (6)

NameTitleBoard
Seat
Contact
Info
David PeraltaChief Executive Officer & Board Member
Susan Ciotti Ph.DDirector, Formulations
Douglas SmithDirector, Immunology
Vira BitkoDirector, Virology
Ali Fattom Ph.DSenior Vice President, Vaccine Research & Development
David Peralta Chief Executive Officer & Board Member
Susan Ciotti Ph.D Director, Formulations
Douglas Smith Director, Immunology
Vira Bitko Director, Virology
Ali Fattom Ph.D Senior Vice President, Vaccine Research & Development

NanoBio Board Members (9)

NameRepresentingRoleSinceContact
Info
Chad CostleySelfBoard Member000 0000
David PeraltaNanoBioChief Executive Officer & Board Member000 0000
David StoutSelfBoard Member000 0000
Gary Costley Ph.DSelfBoard Member000 0000
George AridaVenture InvestorsAdvisor000 0000
Chad Costley Board Member Self
David Peralta Chief Executive Officer & Board Member NanoBio
David Stout Board Member Self
Gary Costley Ph.D Board Member Self
George Arida Advisor Venture Investors
Request full access to PitchBook